In silico evidence of beauvericin antiviral activity against SARS-CoV-2

BACKGROUND: Scientists are still battling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus 2019 (COVID-19) pandemic so human lives can be saved worldwide. Secondary fungal metabolites are of intense interest due to their broad range of pharmaceu...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Khoury, Charbel, Bashir, Zainab, Tokajian, Sima, Nemer, Nabil, Merhi, Georgi, Nemer, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709726/
https://www.ncbi.nlm.nih.gov/pubmed/34968860
http://dx.doi.org/10.1016/j.compbiomed.2021.105171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709726/
https://www.ncbi.nlm.nih.gov/pubmed/34968860
http://dx.doi.org/10.1016/j.compbiomed.2021.105171

Ejemplares similares